---
category: news
title: "AI drug discovery firm spins out of Stanford research"
excerpt: "it spun out of research conducted by its principal founder, Evan Feinberg, at Stanford University. Feinberg is also Genesis Therapeuticsâ€™ CEO. Like many AI-wielding firms, the startup hopes to speed up the drug-discovery process with an eye on severe and debilitating diseases for which medicine is scarce. The firm plans to partner with pharma ..."
publishedDateTime: 2019-12-03T21:28:00Z
sourceUrl: https://medcitynews.com/2019/12/ai-drug-discovery-firm-spins-out-of-stanford-research/
type: article
quality: 137
heat: 137
published: true

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI

images:
  - url: https://www.bing.com/th?id=ON.3D3E53C65A4AC599529269CF59E25DAF
    width: 700
    height: 297
    title: "AI drug discovery firm spins out of Stanford research"

secured: "c1cY9FaIUdzM1WSnOHN0G9GWj7O7yKXkcsgsUBuv93xSXgLGxrn6nbyeAmPWPsUJ8zipyDRv2NN84AmbvgDbCpWVX8+6FIzNn+hXvh4VHxWQQkZRj6C5Hz6jixpYpAW59kuJtn+jOOHWYRWOu8koD6jWycnD6wagQ5/4ycPk9kpcmwAlMb9qa12EvQbwyF4sKnPQ+XgQ82NC1l+qrrYWMRudgVjXX+SdvpEinEQ9AlHy0FKWd8R/gA3dyogr4BtQWH4TEcQ9/GBtwn3aa5Kx2g==;CuBY3kTfwJk2XiPSnf3ewQ=="
---

